Company & Sponsor Intelligence
University Hospital, Bonn
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed2
Countries1
Therapeutic footprint
epilepsyother_neurologyout_of_scopeschizophrenia
Indexed studies
NCT02995447Differential Effects of Propofol on Scalp and Intracranial EEG
out_of_scope · GermanyUNKNOWN
out_of_scope · GermanyUNKNOWN
NCT05320991Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers
schizophrenia · GermanyPHASE4
schizophrenia · GermanyPHASE4
NCT01318018Investigation on the Value of Bilateral Index (BIS) Monitoring for Magnetic Seizure Versus Electroconvulsive Therapy
epilepsy · GermanyCOMPLETED
epilepsy · GermanyCOMPLETED
NCT04137432Oxytocin-augmented Cognitive-behavioral Group-based Short-term Intervention for Loneliness
other_neurology · GermanyPHASE1
other_neurology · GermanyPHASE1
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →